Cargando…
Refinement of the CS6-expressing enterotoxigenic Escherichia coli strain B7A human challenge model: A randomized trial
BACKGROUND: Human challenge models for enterotoxigenic Escherichia coli (ETEC) facilitate vaccine down-selection. The B7A (O148:H28 CS6(+)LT(+)ST(+)) strain is important for vaccine development. We sought to refine the B7A model by identifying a dose and fasting regimen consistently inducing moderat...
Autores principales: | Talaat, Kawsar R., Porter, Chad K., Jaep, Kayla M., Duplessis, Christopher A., Gutierrez, Ramiro L., Maciel, Milton, Adjoodani, Brittany, Feijoo, Brittany, Chakraborty, Subhra, Brubaker, Jessica, Trop, Stefanie A., Riddle, Mark S., Joseph, Sabrina S., Bourgeois, A. Louis, Prouty, Michael G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7710093/ https://www.ncbi.nlm.nih.gov/pubmed/33264302 http://dx.doi.org/10.1371/journal.pone.0239888 |
Ejemplares similares
-
Oral delivery of Hyperimmune bovine serum antibodies against CS6-expressing enterotoxigenic Escherichia coli as a prophylactic against diarrhea
por: Talaat, KR, et al.
Publicado: (2020) -
Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli
por: Lee, Tida, et al.
Publicado: (2021) -
Immune response characterization in a human challenge study with a Shigella flexneri 2a bioconjugate vaccine
por: Clarkson, Kristen A., et al.
Publicado: (2021) -
Human challenge study with a Shigella bioconjugate vaccine: Analyses of clinical efficacy and correlate of protection
por: Talaat, Kawsar R., et al.
Publicado: (2021) -
Clinical endpoints in the controlled human challenge model for Shigella: A call for standardization and the development of a disease severity score
por: Porter, Chad K., et al.
Publicado: (2018)